PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
190 hedge funds and large institutions have $276M invested in PDL BioPharma, Inc. in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $434M → $276M (-$158M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
190
Holding in Top 10
–
Calls
$1.39M
Puts
$227K
Top Buyers
| 1 | +$6.27M | |
| 2 | +$3.14M | |
| 3 | +$2.8M | |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$2.17M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.07M |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$7.67M | |
| 3 | -$2.64M | |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$2.6M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$2.36M |